Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank73
3Y CAGR-7.1%
5Y CAGR+1.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-7.1%/yr
vs +11.0%/yr prior
5Y CAGR
+1.3%/yr
Recent deceleration
Acceleration
-18.1pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$58.03M+28.7%
2024$45.10M-36.7%
2023$71.26M-1.5%
2022$72.38M+5.3%
2021$68.74M+26.1%
2020$54.51M+27.5%
2019$42.74M-10.4%
2018$47.69M+5.6%
2017$45.16M+52.1%
2016$29.70M-